See more : Eugene SPAC X (468760.KQ) Income Statement Analysis – Financial Results
Complete financial analysis of Oxford Nanopore Technologies plc (ONT.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Oxford Nanopore Technologies plc, a leading company in the Biotechnology industry within the Healthcare sector.
- Northern Ocean Ltd. (NOL.OL) Income Statement Analysis – Financial Results
- Embarr Downs, Inc. (EMBR) Income Statement Analysis – Financial Results
- Otis Worldwide Corporation (OTIS) Income Statement Analysis – Financial Results
- Orrön Energy AB (publ) (LNDNF) Income Statement Analysis – Financial Results
- Archer-Daniels-Midland Company (ADM) Income Statement Analysis – Financial Results
Oxford Nanopore Technologies plc (ONT.L)
About Oxford Nanopore Technologies plc
Oxford Nanopore Technologies plc develops and commercializes a technology platform using nanopore-based sensing for the analysis of various types of molecules. The company offers MinION, a portable device for deoxyribonucleic acid and ribonucleic acid sequencing; GridION, a self-contained benchtop device for running and analyzing up to five MinION or Flongle flow cells; MinION Mk1C for basecalling and data analysis, touchscreen operation, and wireless connectivity; Flongle, an adapter for use in MinION or GridION devices to attach a Flongle flow cell; GridION Mk1, a benchtop nanopore sequencer; PromethION 2 Solo and PromethION 2, a low-cost access to high-yield PromethION sequencing; PromethION 24 and PromethION 48 benchtop nanopore-based sequencers for multiple users to deliver multi-sample and multi-experiment sequencing results; and VolTRAX, an USB-powered device, which automates laboratory processes upstream of nanopore sequencing. It also provides MinKNOW, a software that offers data acquisition, real-time analysis and feedback, local basecalling, and data streaming; Basecalling tools to determine the identity and order of bases on the DNA/RNA molecule; EPI2ME, a cloud-based data analysis platform for end-to-end analysis of nanopore data in real time; and EPI2ME Labs, a bioinformatics solution to assist users in developing their skills and confidence in the analysis of their nanopore-based sequencing data. In addition, the company is developing MinION Mk1D; Ubi; Plongle; and SmidgION products. It sells its products online. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies Limited in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is based in Oxford, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 169.67M | 198.60M | 133.66M | 113.86M | 52.06M | 32.52M | 13.79M | 4.53M | 746.00K | 0.00 | 0.00 | 149.49K |
| Cost of Revenue | 79.19M | 74.79M | 60.47M | 66.98M | 26.44M | 16.51M | 7.06M | 3.88M | 564.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 90.48M | 123.81M | 73.20M | 46.88M | 25.62M | 16.02M | 6.73M | 645.00K | 182.00K | 0.00 | 0.00 | 149.49K |
| Gross Profit Ratio | 53.33% | 62.34% | 54.76% | 41.17% | 49.21% | 49.25% | 48.79% | 14.24% | 24.40% | 0.00% | 0.00% | 100.00% |
| Research & Development | 103.84M | 64.84M | 75.98M | 48.55M | 40.46M | 37.10M | 34.98M | 38.11M | 26.66M | 28.36M | 21.04M | 17.57M |
| General & Administrative | 155.25M | 157.45M | 161.75M | 71.39M | 66.06M | 41.09M | 0.00 | 23.64M | 14.63M | 11.03M | 5.68M | 4.17M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.51M | 2.28M | 1.74M | 1.28M | 977.27K |
| SG&A | 155.25M | 157.45M | 161.75M | 71.39M | 66.06M | 41.09M | 37.68M | 26.15M | 16.91M | 12.77M | 6.96M | 5.15M |
| Other Expenses | 0.00 | 0.00 | 504.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 259.09M | 222.29M | 237.73M | 119.94M | 106.51M | 78.19M | 73.11M | 65.99M | 44.50M | 42.12M | 28.99M | 23.62M |
| Cost & Expenses | 338.28M | 297.08M | 298.19M | 186.92M | 132.95M | 94.70M | 80.17M | 69.87M | 45.07M | 42.12M | 28.99M | 23.62M |
| Interest Income | 18.85M | 5.94M | 224.00K | 91.00K | 518.00K | 574.00K | 521.00K | 660.00K | 652.00K | 434.00K | 432.00K | 665.69K |
| Interest Expense | 2.21M | 1.63M | 908.00K | 747.00K | 614.00K | 423.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 41.63M | 31.87M | 24.69M | 17.34M | 14.85M | 6.36M | 1.79M | 1.34M | 1.00M | 1.04M | 936.00K | 892.99K |
| EBITDA | -105.71M | -49.67M | -140.34M | -55.07M | -65.03M | -55.25M | -64.09M | -63.62M | -43.22M | -40.97M | -28.00M | -22.57M |
| EBITDA Ratio | -62.30% | -30.67% | -104.13% | -48.86% | -126.05% | -169.88% | -464.88% | -1,404.64% | -5,792.90% | 0.00% | 0.00% | -15,097.05% |
| Operating Income | -168.61M | -98.48M | -164.53M | -73.06M | -80.89M | -62.18M | -65.89M | -64.96M | -44.22M | -42.01M | -28.94M | -23.46M |
| Operating Income Ratio | -99.38% | -49.59% | -123.10% | -64.17% | -155.38% | -191.19% | -477.89% | -1,434.29% | -5,927.08% | 0.00% | 0.00% | -15,694.40% |
| Total Other Income/Expenses | 18.84M | 15.07M | -1.47M | -93.00K | 409.00K | 151.00K | 21.00K | 274.00K | 548.00K | 321.00K | 378.00K | 657.56K |
| Income Before Tax | -149.77M | -83.41M | -166.00M | -73.15M | -80.48M | -62.03M | -65.87M | -64.69M | -43.67M | -41.69M | -28.56M | -22.80M |
| Income Before Tax Ratio | -88.27% | -42.00% | -124.20% | -64.25% | -154.60% | -190.72% | -477.74% | -1,428.24% | -5,853.62% | 0.00% | 0.00% | -15,254.54% |
| Income Tax Expense | 4.74M | 7.61M | 1.61M | -11.91M | -8.27M | -8.91M | 9.33M | 5.58M | 5.16M | 4.72M | 4.35M | 3.64M |
| Net Income | -154.51M | -91.03M | -167.61M | -61.24M | -72.22M | -53.12M | -56.54M | -59.10M | -38.51M | -36.97M | -24.22M | -19.16M |
| Net Income Ratio | -91.06% | -45.83% | -125.40% | -53.79% | -138.71% | -163.34% | -410.07% | -1,304.95% | -5,162.33% | 0.00% | 0.00% | -12,816.49% |
| EPS | -0.19 | -0.11 | -0.20 | -0.08 | -0.09 | -0.07 | -0.10 | -0.11 | -0.08 | -0.08 | -0.06 | -0.05 |
| EPS Diluted | -0.19 | -0.11 | -0.20 | -0.08 | -0.09 | -0.07 | -0.10 | -0.11 | -0.08 | -0.08 | -0.06 | -0.05 |
| Weighted Avg Shares Out | 833.96M | 823.74M | 821.56M | 794.67M | 794.67M | 794.67M | 541.13M | 539.36M | 491.39M | 449.80M | 417.12M | 383.67M |
| Weighted Avg Shares Out (Dil) | 833.96M | 823.74M | 821.56M | 794.67M | 794.67M | 794.67M | 541.12M | 539.36M | 491.39M | 449.80M | 417.11M | 383.67M |
Source: https://incomestatements.info
Category: Stock Reports